$124.04
0.56% yesterday
Nasdaq, May 23, 09:49 pm CET
ISIN
US89377M1099
Symbol
TMDX

TransMedics Group, Inc. Target price 2025 - Analyst rating & recommendation

TransMedics Group, Inc. Classifications & Recommendation:

Buy
70%
Hold
30%

TransMedics Group, Inc. Price Target

Target Price $125.88
Price $124.25
Potential
Number of Estimates 8
8 Analysts have issued a price target TransMedics Group, Inc. 2026 . The average TransMedics Group, Inc. target price is $125.88. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 7 Analysts recommend TransMedics Group, Inc. to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the TransMedics Group, Inc. stock has an average upside potential 2026 of . Most analysts recommend the TransMedics Group, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 441.54 580.27
82.74% 31.42%
EBITDA Margin 8.54% 20.57%
3,396.65% 140.91%
Net Margin 8.03% 10.59%
177.52% 31.86%

10 Analysts have issued a sales forecast TransMedics Group, Inc. 2025 . The average TransMedics Group, Inc. sales estimate is

$580m
Unlock
. This is
18.85% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$585m 19.90%
Unlock
, the lowest is
$576m 18.03%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $442m 82.74%
2025
$580m 31.42%
Unlock
2026
$696m 20.02%
Unlock
2027
$814m 16.83%
Unlock
2028
$1.0b 23.67%
Unlock
2029
$1.1b 11.25%
Unlock

5 Analysts have issued an TransMedics Group, Inc. EBITDA forecast 2025. The average TransMedics Group, Inc. EBITDA estimate is

$119m
Unlock
. This is
125.96% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$136m 156.53%
Unlock
, the lowest is
$95.9m 81.48%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $37.7m 6,289.83%
2025
$119m 216.59%
Unlock
2026
$163m 36.98%
Unlock
2027
$212m 29.63%
Unlock
2028
$355m 67.56%
Unlock
2029
$445m 25.34%
Unlock

EBITDA Margin

2024 8.54% 3,396.65%
2025
20.57% 140.91%
Unlock
2026
23.47% 14.10%
Unlock
2027
26.04% 10.95%
Unlock
2028
35.29% 35.52%
Unlock
2029
39.76% 12.67%
Unlock

7 TransMedics Group, Inc. Analysts have issued a net profit forecast 2025. The average TransMedics Group, Inc. net profit estimate is

$61.5m
Unlock
. This is
25.58% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$65.3m 33.38%
Unlock
, the lowest is
$58.2m 18.88%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $35.5m 241.67%
2025
$61.5m 73.35%
Unlock
2026
$82.2m 33.74%
Unlock
2027
$94.8m 15.30%
Unlock
2028
$124m 30.80%
Unlock
2029
$144m 16.24%
Unlock

Net Margin

2024 8.03% 177.52%
2025
10.59% 31.86%
Unlock
2026
11.80% 11.43%
Unlock
2027
11.65% 1.27%
Unlock
2028
12.32% 5.75%
Unlock
2029
12.87% 4.46%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 1.01 1.82
231.17% 80.20%
P/E 68.38
EV/Sales 7.59

7 Analysts have issued a TransMedics Group, Inc. forecast for earnings per share. The average TransMedics Group, Inc. EPS is

$1.82
Unlock
. This is
49.18% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$1.93 58.20%
Unlock
, the lowest is
$1.72 40.98%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $1.01 231.17%
2025
$1.82 80.20%
Unlock
2026
$2.43 33.52%
Unlock
2027
$2.80 15.23%
Unlock
2028
$3.67 31.07%
Unlock
2029
$4.26 16.08%
Unlock

P/E ratio

Current 101.84 121.41%
2025
68.38 32.86%
Unlock
2026
51.13 25.23%
Unlock
2027
44.34 13.28%
Unlock
2028
33.90 23.55%
Unlock
2029
29.17 13.95%
Unlock

Based on analysts' sales estimates for 2025, the TransMedics Group, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 9.02 43.02%
2025
7.59 15.86%
Unlock
2026
6.32 16.68%
Unlock
2027
5.41 14.41%
Unlock
2028
4.38 19.14%
Unlock
2029
3.93 10.11%
Unlock

P/S ratio

Current 8.61 43.75%
2025
7.24 15.86%
Unlock
2026
6.04 16.68%
Unlock
2027
5.17 14.41%
Unlock
2028
4.18 19.14%
Unlock
2029
3.76 10.11%
Unlock

Current TransMedics Group, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Piper Sandler
Locked
Locked
Locked May 09 2025
Oppenheimer
Locked
Locked
Locked May 09 2025
Piper Sandler
Locked
Locked
Locked Apr 29 2025
Needham
Locked
Locked
Locked Apr 23 2025
Needham
Locked
Locked
Locked Mar 26 2025
Canaccord Genuity
Locked
Locked
Locked Mar 11 2025
Needham
Locked
Locked
Locked Feb 05 2025
Analyst Rating Date
Locked
Piper Sandler:
Locked
Locked
May 09 2025
Locked
Oppenheimer:
Locked
Locked
May 09 2025
Locked
Piper Sandler:
Locked
Locked
Apr 29 2025
Locked
Needham:
Locked
Locked
Apr 23 2025
Locked
Needham:
Locked
Locked
Mar 26 2025
Locked
Canaccord Genuity:
Locked
Locked
Mar 11 2025
Locked
Needham:
Locked
Locked
Feb 05 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today